InsidersTradesSigma
Follow the 엔케이젠바이오텍코리아 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 엔케이젠바이오텍코리아 has recorded 1 reports. Market capitalisation: €516.3bn. The latest transaction was filed on 22 April 2026 (Other). Among the most active insiders: NKGenBiotech,Inc.. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
엔케이젠바이오텍코리아 是一家在XKRX市场上市的健康和制药公司。它专注于开发创新的生物制药解决方案。